Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of in-season Grazax for grass pollen-induced rhinoconjunctivitis
2007-006009-26Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Jan 2008
- Countries
- 1
01
Overview
Phase 3 trial of phleum pratense allergen extract in allergic rhinitis (AR) and seasonal allergic rhinitis (SAR) (2 arms), sponsored by ALK-Abelló. Primary endpoint: IgE blocking antibodies at visit 4. Started Jan 2008; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinitis (AR)seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2007-006009-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006009-26.